Incidence of febrile neutropenia in lymphoma patients receiving CHOP with Day 1 or 2 pegfilgrastim.

e18562 Background: Febrile neutropenia is a rare, but serious consequence of chemotherapy that can be fatal. The current guidelines set forth by the American Society of Clinical Oncology (ASCO) rec...